Journals / Experimental Biomedical Research / 2021 / Cilt: 4 - Sayı: 1

Evaluation of epicardial fat tissue thickness in patients with multiple sclerosis

Pages
58–64
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, the clinical significance of this finding and its relevance to MS pathogenesis should be investigated in further studies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Multiple sclerosis (MS), which is inflammatory in its pathogenesis, damages the myelin sheath in the central nervous system (CNS) and causes axonal loss.
📊
Key Findings & Data:Methods: A total of 154 subjects comprising 61 MS patients and 93 volunteers matched for gender and age were included in our study.
💡
Conclusion & Impact:However, the clinical significance of this finding and its relevance to MS pathogenesis should be investigated in further studies.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Aim: Multiple sclerosis (MS), which is inflammatory in its pathogenesis, damages the myelin sheath in the central nervous system (CNS) and causes axonal loss. Epicardial fat tissue (EFT), located between the myocardium and the visceral layer of the pericardium, surrounds the heart and several inflammatory cytokines is secreted from this tissue. In this study, we aimed to investigate EFT thickness in MS patients and compared with that of volunteer non-MS subjects. Methods: A total of 154 subjects comprising 61 MS patients and 93 volunteers matched for gender and age were included in our study. Epicardial fat tissue thickness was measured by echocardiography. All values were compared between groups.Results: Echocardiographic parameters were similar in both groups. However, the mean EFT thickness was significantly higher in the MS group than in the control group (p<0.001). Epicardial fat tissue thickness was also significantly correlated with the presence of MS (r=0.33, p<0.001). Conclusion: The results of our study suggest that the increase in epicardial adipose tissue thickness in MS patients may be a predictive factor for cardiovascular disease. However, the clinical significance of this finding and its relevance to MS pathogenesis should be investigated in further studies.

🔖

Cite This Article

COŞGUN, M., SİNCER, İ., YILMAZ, G. N., KÖK, Z., TÜRKOĞLU, Ş. A. (2021). Evaluation of epicardial fat tissue thickness in patients with multiple sclerosis. Experimental Biomedical Research, Cilt: 4 - Sayı: 1, 58–64. https://ajindex.com/articles/201529

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Belbasis L, Bellou V, Evangelou E, et al. Environmental risk factors and multiple sclerosis: An umbrella review of systematic reviews and metaanalyses. Lancet Neurol. 2015;14(3):263–73
  2. Sawcer S, Franklin RJ, Ban M. Multiple sclerosis genetics. Lancet Neurol. 2014;13(7):700–9
  3. Brück, W, Stadelmann C. The spectrum of multiple sclerosis: new lessons from pathology. Curr Opin Neurol. 2005;18(3):221–24
  4. Hohlfeld R, Kerschensteiner M, Stadelmann C, et al. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. J Neuroimmunol. 2000;107(2):161-66
  5. Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J. 2007;153(6): 907-17
  6. Şengul C, Özveren O. Epicardial adipose tissue: a review of physiology, pathophysiology, and clinical applications. Anadolu Kardiyol Derg. 2013;13(3):261-65
  7. Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108(20):2460-66
  8. Kim SH, Chung JH, Kwon BJ, et al. The Associations of Epicardial Adipose Tissue With Coronary Artery Disease and Coronary Atherosclerosis. Int Heart J. 2014;55(3):197-203
  9. Imitola J, Chitnis T, Khoury SJ. Cytokines in multiple sclerosis: from bench to bedside. Pharmacol Ther. 2005;106(2):163- 77
  10. Stys PK. Multiple sclerosis: autoimmune disease or autoimmune reaction? Can J Neurol Sci. 2010;37(S2):S16-S23
  11. Asik M, Sahin S, Ozkul F, et al. Evaluation of epicardial fat tissue thickness in patients with Hashimoto thyroiditis. Clin Endocrinol. 2013;79(4):571-76
  12. Fatma E, Bunyamin K, Savas S, et al. Epicardial fat thickness in patients with rheumatoid arthritis. Afr Health Sci. 2015;15(2):489-95
  13. Iacobellis G, Barbaro G. The double role of epicardial adipose tissue as pro-and antiinflammatory organ. Horm Metab Res. 2008;40(07):442-45
  14. Iacobellis G, Assael F, Ribaudo MC, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res. 2003;11(2):304-10
  15. Jadidi E, Mohammadi M, Moradi T. High risk of cardiovascular diseases after diagnosis of multiple sclerosis. Mult Scler. 2013;19(10):1336–40
  16. Christiansen CF, Christensen S, Farkas DK, et al. Risk of arterial cardiovascular diseases in patients with multiple sclerosis: a population‐based cohort study. Neuroepidemiology. 2010;35(4):267 –74
  17. Allen NB, Lichtman JH, Cohen HW, et al. Vascular disease among hospitalized multiple sclerosi